Spectral-domain Optical Coherence Tomography of the Eye

NCT ID: NCT02614625

Last Updated: 2015-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An increasing number of clinical studies on SD-OCT of ocular pathologies and potential new clinical applications has recently been published in the peer-reviewed literature. However, the successful use of SD-OCT in routine clinical use depends upon the diagnostic sensitivity, biometric accuracy and reliability of the SD-OCT machines. This prospective, comparative, observational study aims to evaluate the imaging quality and diagnostic performance of two commercially available SD-OCT machines for both the anterior and posterior segment of the eye.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cornea Retina Refractive Surgery Macular Edema Diabetes Diabetic Macular Edema

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal subjects

Patient with healthy, normal eyes

No interventions assigned to this group

Eyes with corneal disease

Subjects that have any of the following conditions

* Corneal dystrophy or degeneration
* Corneal scarring
* Corneal ulcer
* Corneal injury
* Keratoconus
* Patients who had undergone corneal surgery
* Patients with other corneal disease

No interventions assigned to this group

Eyes with retinal disease

Subjects that have any of the following conditions:

* Diabetic macular edema
* Cystoid macular edema
* Age related macular degeneration
* Retinal vascular disorders (e.g. retinal artery occlusion)
* Epiretinal membrane
* Choroidal nevus
* Macular hole
* Patients who had undergone retinal surgery
* Patients with other retinal disease

No interventions assigned to this group

Eyes with glaucoma

Eyes diagnosed with glaucoma of any type and any stage

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21 and older
* Normal eyes or
* Eyes with corneal disease:

Subjects that have any of the following conditions

1. Corneal dystrophy or degeneration
2. Corneal scarring
3. Corneal ulcer
4. Corneal injury
5. Keratoconus
6. Patients who had undergone corneal surgery
7. Patients with other corneal disease or - Eyes with retinal disease:

Subjects that have any of the following conditions:

1. Diabetic macular edema
2. Cystoid macular edema
3. Age related macular degeneration
4. Retinal vascular disorders (e.g. retinal artery occlusion)
5. Epiretinal membrane
6. Choroidal nevus
7. Macular hole
8. Patients who had undergone retinal surgery
9. Patients with other retinal disease or

* Eyes with glaucoma
* Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant.

AND

\- Written informed consent prior to recruitment

Exclusion Criteria

Any of the following will exclude a subject from the study:

* Patients who are not able to cooperate or with insufficient ability to fixate (tremor, nystagmus)
* Pregnancy (pregnancy test will be taken in women of reproductive age before enrolment into the trial)
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Augenabteilung Allgemeines Krankenhaus Linz

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matthias Bolz, MD

Role: PRINCIPAL_INVESTIGATOR

AKh Linz, Augenabteilung

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AKh Linz

Linz, Upper Austria, Austria

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Austria

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nikolaus Luft, MD

Role: CONTACT

+43 732 7806 ext. 1050

References

Explore related publications, articles, or registry entries linked to this study.

Luft N, Ring MH, Dirisamer M, Mursch-Edlmayr AS, Kreutzer TC, Pretzl J, Bolz M, Priglinger SG. Corneal Epithelial Remodeling Induced by Small Incision Lenticule Extraction (SMILE). Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT176-83. doi: 10.1167/iovs.15-18879.

Reference Type DERIVED
PMID: 27409470 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OCTComparisonstudy1.1

Identifier Type: -

Identifier Source: org_study_id